The CEA Registry Blog

Feb 1

by CEA Registry Team 2/1/2012 10:47 AM  RssIcon

Twice each month we highlight recently published cost-utility studies and selected reviews and editorials.

1. Maheswaran H, Barton P. Intensive Case Finding and Isoniazid Preventative Therapy in HIV Infected Individuals in Africa: Economic Model and Value of Information Analysis. PLoS One. 2012;7(1):e30457. Epub 2012 Jan 23. PubMed PMID: 22291958.

2. Dakin H, Gray A, Fitzpatrick R, et al. The KAT Trial Group. Rationing of total knee replacement: a cost-effectiveness analysis on a large trial data set. BMJ Open. 2012 Jan 30;2(1):e000332. Print 2012. PubMed PMID: 22290396.

3. Athanasakis K, Fragoulakis V, Tsiantou V, et al. Cost-Effectiveness Analysis of Ranibizumab versus Verteporfin Photodynamic Therapy, Pegaptanib Sodium, and Best Supportive Care for the Treatment of Age-Related Macular Degeneration in Greece. Clin Ther. 2012 Jan 28. [Epub ahead of print] PubMed PMID: 22289279.

4. Yang H, Craig D, Epstein D, et al. Treatment of Psoriatic Arthritis: A NICE Single Technology Appraisal. Pharmacoeconomics. 2012 Jan 27. [Epub ahead of print] PubMed PMID: 22283690.

5. Akunne A, Murthy L, Young J. Cost-effectiveness of multi-component interventions to prevent delirium in older people admitted to medical wards. Age Ageing. 2012 Jan 26. [Epub ahead of print] PubMed PMID: 22282171.

6. Albers-Heitner PC, Joore MM, Winkens RR, et al. Cost-effectiveness of involving nurse specialists for adult patients with urinary incontinence in primary care compared to care-as-usual: An economic evaluation alongside a pragmatic randomized controlled trial. Neurourol Urodyn. 2012 Jan 24. [Epub ahead of print] PubMed PMID: 22275126.

7. Park KT, Tsai R, Perez F, et al. Cost-Effectiveness of Early Colectomy With Ileal Pouch-Anal Anastamosis Versus Standard Medical Therapy in Severe Ulcerative Colitis. Ann Surg. 2012 Jan 20. [Epub ahead of print] PubMed PMID: 22270693.

8. Iannazzo S, Carsi M, Chiroli S. A Cost-Utility Analysis of Cinacalcet in Secondary Hyperparathyroidism in Five European Countries. Appl Health Econ Health Policy. 2012 Jan 23. doi: 10.2165/11597980-000000000-00000. [Epub ahead of print] PubMed PMID: 22268372.

9. Cheng TF, Wang JD, Uen WC. Cost-utility analysis of adjuvant goserelin (Zoladex) and adjuvant chemotherapy in premenopausal women with breast cancer. BMC Cancer. 2012 Jan 21;12(1):33. [Epub ahead of print] PubMed PMID: 22264299.

10. Brereton N, Winn B, Akehurst R. The cost effectiveness of celecoxib versus diclofenac in the treatment of osteoarthritis in the UK; an update to the NICE model using data from the CONDOR trial. J Med Econ. 2012 Jan 20. [Epub ahead of print] PubMed PMID: 22260652.

11. Apeldoorn AT, Bosmans JE, Ostelo RW, et al. Cost-effectiveness of a classification-based system for sub-acute and chronic low back pain. Eur Spine J. 2012 Jan 19. [Epub ahead of print] PubMed PMID: 22258622.

12. Berger M, Xu X, Williams J, Van de Ven C, Mozurkewich E. Early hospital discharge of infants born to group B streptococci-positive mothers: a decision analysis. BJOG. 2012 Jan 18. [Epub ahead of print] PubMed PMID: 22251453.

13. van Rosmalen J, de Kok I, van Ballegooijen M. Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing. BJOG. 2012 Jan 18. [Epub ahead of print] PubMed PMID: 22251259.

14. Shimizu U, Saito S, Ling Y, et al. Cost effectiveness achieved through changing the composition of renal replacement therapy in Japan. J Med Econ. 2012 Jan 18. [Epub ahead of print] PubMed PMID: 22250787.

15. Sánchez-de la Rosa R, Sabater E, Casado MA, et al. Cost-effectiveness analysis of disease modifiying drugs (interferons and glatiramer acetate) as first line treatments in remitting-relapsing multiple sclerosis patients. J Med Econ. 2012 Jan 27. [Epub ahead of print] PubMed PMID: 22217249.

16. Galper BZ, Moran A, Coxson PG, et al. Using stress testing to guide primary prevention of coronary heart disease among intermediate-risk patients: a cost-effectiveness analysis. Circulation. 2012 Jan 17;125(2):260-70. Epub 2011 Dec 5. PubMed PMID: 22144567

17. Mauskopf J, Brogan AJ, Talbird SE, et al. Cost-effectiveness of combination therapy with etravirine in treatment-experienced adults with HIV-1 infection. AIDS. 2012 Jan 28;26(3):355-64. PubMed PMID: 22089378.

By Teja Thorat

Tags:
Categories:

Your name:
Title:
Comment:
Security Code
CAPTCHA image
Enter the code shown above in the box below
Add Comment   Cancel 

Please view the blog archive for earlier entries

Search This Blog